BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announce that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) on the fully-automated BD MAX™ System. Together with the BD Phoenix™ CPO Detect Panels, BD provides solutions for screening and infection management to support clinical microbiology laboratories...

BD (Becton Dickinson and Company), a leading global medical technology company, has announced the CE-IVDD certification of the BD COR™ System in Europe. The high throughput solution for infectious disease diagnostics sets a new standard in automation for molecular testing in core laboratories and other large centralized laboratories...

BD FACSDuet™ system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric™ clinical flow cytometer. BD (Becton, Dickinson and Company), a leading global medical technology company, has announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. The new fully automated sample preparation instrument enables clinical laboratories to improve their efficiency by reducing errors....

BD, a leading global medical technology company, has announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix™ CPO detect test, which will allow hospitals to identify infections caused by carbapenemase-producing organisms (CPOs). The test may help hospitals contain the spread of antimicrobial resistance (AMR) by shortening the time it takes to detect CPOs, thereby enabling the earlier implementation of infection control procedures and...

By Rajeev Sehgal, Director of Informatics at BD (Becton, Dickinson and Company)

Microbiology laboratories are facing challenges on a number of fronts: cost pressures and staff shortages constrain their ability to process samples, and increasing test volumes make it difficult for some labs to run tests and get results back to clinicians in a timely manner. Microbiology labs are constantly juggling at least four key priorities....

BD (Becton, Dickinson and Company), a leading global medical technology company, has introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance....

CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes a proprietary...

BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in the UK and Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time. BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect...